NCT02628067 2025-09-22KEYNOTE 158Merck Sharp & Dohme LLCPhase 2 Active not recruiting1,609 enrolled 5 FDA
NCT00986661 2022-11-02A Study to Assess PV-10 Chemoablation of Cancer of the LiverProvectus PharmaceuticalsPhase 1 Unknown78 enrolled
NCT01327612 2021-02-21Open Label Extension Study of Conatumumab and Ganitumab (AMG 479)AmgenPhase 2 Completed12 enrolled 21 charts
NCT01165658 2020-01-02Study of Hypofractionated Proton Radiation Therapy in Thoracic MalignanciesM.D. Anderson Cancer CenterPhase 1 Terminated30 enrolled
NCT00580320 2016-08-18Safety Study of Dacarbazine and Bortezomib in Melanoma and Soft Tissue SarcomaVirginia Commonwealth UniversityPhase 1 Completed17 enrolled